drugset / Trial / NCT02931123

A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY

NCT02931123

Phase 1/2 Unknown 58 enrolled University of Roma La Sapienza
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a randomized controlled trial whose purpose is to evaluate the efficacy of therapy with lactulose and rifaximin associated with a vegetable diet in the prevention of post-TIPS hepatic encephalopathy.

Timeline

Start
2015-11
Primary completion
2017-11
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject lattulose Unknown
Subject rifaximine Unknown

Indications

No indication recorded.